Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $2.05 Million - $2.33 Million
-18,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$101.14 - $118.31 $262,964 - $307,606
-2,600 Reduced 12.62%
18,000 $2.04 Million
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $2.21 Million - $3.13 Million
20,600 New
20,600 $2.32 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mountain Lake Investment Management LLC Portfolio

Follow Mountain Lake Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mountain Lake Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mountain Lake Investment Management LLC with notifications on news.